Tenax Therapeutics (TENX) Shares Outstanding (Weighted Average) (2010 - 2026)
Tenax Therapeutics recorded quarterly Shares Outstanding (Weighted Average) of $45.2 million in Q1 2026, up 167.69% quarter-over-quarter from $16.9 million in Q4 2025, and up 128.39% year-over-year from $19.8 million in Q1 2025.
Tenax Therapeutics' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $45.2 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 128.39% year-over-year to $45.2 million; the TTM figure through Mar 2026 stood at $45.2 million (up 128.39% YoY), while the FY2025 annual figure was $39.2 million, up 156.8% from the prior year.
- Shares Outstanding (Weighted Average) came in at $45.2 million for Q1 2026 at Tenax Therapeutics, up from $16.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $45.2 million in Q1 2026 to a low of $19694.0 in Q4 2023.
- A 5-year average of $11.4 million and a median of $3.2 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) sank 98.84% in 2023 and jumped 77444.96% in 2024, its largest moves.
- Tenax Therapeutics' Shares Outstanding (Weighted Average) stood at $19703.0 in 2022, then decreased by 0.05% to $19694.0 in 2023, then surged by 77444.96% to $15.3 million in 2024, then grew by 10.63% to $16.9 million in 2025, then soared by 167.69% to $45.2 million in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $45.2 million, $16.9 million, and $19.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | 45.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.23 Mn |
| Dec 31, 2025 | 16.90 Mn |
| Sep 30, 2025 | 19.08 Mn |
| Jun 30, 2025 | 38.09 Mn |
| Mar 31, 2025 | 19.80 Mn |
| Dec 31, 2024 | 15.27 Mn |
| Sep 30, 2024 | 19.89 Mn |
| Jun 30, 2024 | 1.96 Mn |
| Mar 31, 2024 | 3.22 Mn |
| Dec 31, 2023 | 19,694.00 |
| Sep 30, 2023 | 298,280.00 |
| Jun 30, 2023 | 276,454.00 |
| Mar 31, 2023 | 116,259.00 |
| Dec 31, 2022 | 19,703.00 |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 10.03 Mn |
| Dec 31, 2021 | 13,080.00 |
| Sep 30, 2021 | 10.03 Mn |
| Jun 30, 2021 | 17.22 Mn |
| Mar 31, 2021 | 14.52 Mn |
| Dec 31, 2020 | 10.37 Mn |
| Sep 30, 2020 | 20.95 Mn |
| Jun 30, 2020 | 9.34 Mn |
| Mar 31, 2020 | 6.97 Mn |
| Dec 31, 2019 | 6.20 Mn |
| Sep 30, 2019 | 10.52 Mn |
| Jun 30, 2019 | 6.39 Mn |
| Mar 31, 2019 | 4.89 Mn |
| Dec 31, 2018 | 1.56 Mn |
| Sep 30, 2018 | 1.45 Mn |
| Jun 30, 2018 | 120,773.00 |
| Mar 31, 2018 | 1.42 Mn |
| Dec 31, 2017 | 1.41 Mn |
| Sep 30, 2017 | 1.41 Mn |
| Jun 30, 2017 | 1.41 Mn |
| Mar 31, 2017 | 1.41 Mn |
| Dec 31, 2016 | 1.41 Mn |
| Sep 30, 2016 | 28.12 Mn |
| Jun 30, 2016 | 28.12 Mn |
| Mar 31, 2016 | 28.12 Mn |
| Dec 31, 2015 | 28.12 Mn |
| Sep 30, 2015 | 28.12 Mn |
| Jun 30, 2015 | 28.12 Mn |
| Apr 30, 2015 | 28.08 Mn |
| Jan 31, 2015 | 28.12 Mn |
| Oct 31, 2014 | 28.04 Mn |
| Jul 31, 2014 | 27.66 Mn |
| Apr 30, 2014 | 9.36 Mn |
| Jan 31, 2014 | 5.81 Mn |
| Oct 31, 2013 | 4.94 Mn |
| Jul 31, 2013 | 2.10 Mn |
| Apr 30, 2013 | 3.02 Mn |
| Jan 31, 2013 | 1.59 Mn |
| Oct 31, 2012 | 1.60 Mn |
| Jul 31, 2012 | 1.51 Mn |
| Apr 30, 2012 | 1.30 Mn |
| Jan 31, 2012 | 24.92 Mn |
| Oct 31, 2011 | 23.60 Mn |
| Jul 31, 2011 | 23.40 Mn |
| Apr 30, 2011 | 23.35 Mn |
| Jan 31, 2011 | 23.39 Mn |
| Oct 31, 2010 | 23.30 Mn |
| Jul 31, 2010 | 23.22 Mn |